SSA
CLBT icon

Schonfeld Strategic Advisors’s Cellebrite CLBT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,150
Closed -$402K – 2246
2025
Q2 		$402K Sell
25,150
-5,148
-17% -$91.8K ﹤0.01% 1609
2025
Q1 		$589K Sell
30,298
-49,702
-62% -$1.05M ﹤0.01% 1514
2024
Q4 		$1.76M Buy
+80,000
New +$1.54M 0.01% 887
2024
Q3 		– Sell
-67,000
Closed -$801K – 2084
2024
Q2 		$801K Buy
67,000
+24,700
+58% +$276K 0.01% 1296
2024
Q1 		$469K Sell
42,300
-23,000
-35% -$235K ﹤0.01% 1499
2023
Q4 		$565K Buy
65,300
+54,700
+516% +$425K ﹤0.01% 1242
2023
Q3 		$81.1K Buy
+10,600
New +$79.6K ﹤0.01% 1509
2022
Q2 		– Sell
-22,324
Closed -$143K – 2594
2022
Q1 		$143K Buy
+22,324
New +$148K ﹤0.01% 2121

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Schonfeld Strategic Advisors's CLBT Position: Q3 2025 in Review

Schonfeld Strategic Advisors sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 25,150 shares — an estimated $402K sold.

Schonfeld Strategic Advisors first reported a position in CLBT in Q1 2022 and held it in 8 quarters. The position peaked at $1.76M in Q4 2024. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Schonfeld Strategic Advisors reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 25,150 Cellebrite shares in Q3 2025, an estimated $402K.
  • Schonfeld Strategic Advisors first reported a position in Cellebrite in Q1 2022 and held it in 8 quarters.
  • Schonfeld Strategic Advisors's Cellebrite position peaked at $1.76M in Q4 2024.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.